(Q44346348)

2 December 2017

title

The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study (English)

1 reference

2 December 2017

author name string

Oral Contraceptive and Hemostasis Study Group

series ordinal

1

1 reference

2 December 2017

language of work or name

1 reference

1 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

67

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

173-185

1 reference

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Oral contraceptives and venous thromboembolism. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

The risks of venous thromboembolic disease among German women using oral contraceptives: a database study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

First-time use of newer oral contraceptives and the risk of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

The differential risk of oral contraceptives: the impact of full exposure history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Recurrent use of newer oral contraceptives and the risk of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Acquired APC resistance and oral contraceptives: differences between two functional tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Importance of levonorgestrel dose in oral contraceptives for effects on coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Factor VII, cholesterol, and triglycerides. The CARDIA Study. Coronary Artery Risk Development in Young Adults Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Factor VIIA determination compared to D-Dimer in diagnosis of deep venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Effects of two combined monophasic and triphasic ethinylestradiol/gestodene oral contraceptives on natural inhibitors and other hemostatic variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Mortality among women participating in the Oxford/Family Planning Association contraceptive study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Oral contraceptives and venous thromboembolism: an epidemiological review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Evaluation of hypercoagulability in users of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Coagulation effects of oral contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

A comparative study on the effects of a monophasic pill containing desogestrel plus 20 μg ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

Oral contraceptives and venous thromboembolism: findings in a large prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2802%2900476-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-7824(02)00476-6

1 reference

2 December 2017

1 reference